Anders Berkenstam
Gründer bei Axcentua Pharmaceuticals AB
Profil
Anders Berkenstam is the founder of Axcentua Pharmaceuticals AB, which was founded in 2007.
He holds the title of Director & Chief Scientific Officer at the company.
Dr. Berkenstam also worked as an Associate Professor at Karolinska Institutet.
He obtained a doctorate degree from Karolinska Institutet.
Aktive Positionen von Anders Berkenstam
| Unternehmen | Position | Beginn |
|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Gründer | 17.09.2009 |
Ehemalige bekannte Positionen von Anders Berkenstam
| Unternehmen | Position | Ende |
|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | - |
Ausbildung von Anders Berkenstam
| Karolinska Institutet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
